Previous studies have suggested that Jag2 may accelerate the development of hypoxic PAH by inhibiting the Nrf2/HO‐1 pathway and enhancing Sirtuin 1‐mediated oxidative stress, cell proliferation, and mitochondrial damage.48 The gene discussed is JAG2; the disease is pulmonary arterial hypertension.